Mitchell Levine

Mitchell Levine

Chairman chez IMMUNOPRECISE ANTIBODIES LTD.

Fortune : 30 400 $ au 31/03/2024

Finance
Health Technology
Consumer Services

Profil

Mitchell Stuart Levine is the founder of Enable Global Capital LLC, which was founded in 2002.
He held the title of Managing Member & Chief Compliance Officer at Enable Global Capital LLC from 2011 to 2017.
Mr. Levine is currently the Chairman & Chief Executive Officer at Smart Health Diagnostics Co. since 2022 and the Chairman at ImmunoPrecise Antibodies Ltd.
since 2023.
Mr. Levine has held former positions as Principal at Bear, Stearns & Co., Inc., Principal at Lehman Brothers Distressed Structured Credit Capital Partners, Principal at The Shemano Group, Inc., Managing Partner at Cove Capital Advisors, Inc., and Chief Financial Officer at OncoCyte Corp.
from 2017 to 2022.
Mr. Levine obtained his undergraduate degree from the University of California, Davis.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
21/03/2024 20 000 ( 0,08% ) 30 400 $ 31/03/2024

Postes actifs de Mitchell Levine

SociétésPosteDébut
IMMUNOPRECISE ANTIBODIES LTD. Chairman 27/11/2023
Chief Executive Officer 01/11/2022
Tous les postes actifs de Mitchell Levine

Anciens postes connus de Mitchell Levine

SociétésPosteFin
Founder 01/01/2017
Cove Capital Advisors, Inc. Corporate Officer/Principal -
ONCOCYTE CORPORATION Director of Finance/CFO 01/06/2022
Lehman Brothers Distressed Structured Credit Capital Partners Corporate Officer/Principal -
Corporate Officer/Principal -
Voir l'expérience en détail de Mitchell Levine

Formation de Mitchell Levine

University of California, Davis Undergraduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Mitchell Levine

Relations

18

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
ONCOCYTE CORPORATION

Health Technology

IMMUNOPRECISE ANTIBODIES LTD.

Health Technology

Entreprise privées6

Finance

Lehman Brothers Distressed Structured Credit Capital Partners

Finance

Finance

Cove Capital Advisors, Inc.

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Mitchell Levine